Company | M&T Bank Corporation |
Ticker | MTB (NYSE) |
Upcoming Earnings Date | July 16, 2026 (est.) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Prepared | July 14, 2026 |
Key Takeaway: The setup into Q2 2026 is modestly constructive — consensus has been revised up since Q1 earnings and the bar is achievable, but the single biggest swing factor is whether CRE loan balances finally inflect to net growth, which management has been signaling with high conviction since May.
Heading into the Q2 2026 print, the consensus bar for MTB looks beatable but not easy. Operating EPS consensus sits at $4.68 (vs. $4.13 in Q1 2026 and $4.22 in Q2 2025), implying a meaningful sequential step-up that is largely predicated on NII recovery and continued fee momentum. Management guided NII toward the bottom half of the $7.2–$7.35 billion full-year range after Q1, but at the May Barclays conference and June Morgan Stanley conference, tone shifted materially — CFO Daryl Bible stated CRE "is going to grow this year, probably in the next quarter or two" with "very, very good positive momentum," and CEO René Jones described loan growth as "very healthy" with customers beginning to draw down lines, consistent with the normal credit cycle inflection. Fee income is the clearest bright spot: management signaled fees may exceed the top of their guidance range, driven by mortgage banking, capital markets, corporate trust, and Bayview distributions, and the Q1 13% YoY fee growth trajectory supports this. On the stock, MTB has rallied ~10% since Q1 earnings (from ~$217 to ~$242), outperforming both KRE (+8%) and SPY (+7%), suggesting the market has partially priced in the improving narrative — but not fully, as the stock still trades at a modest discount to its ROTCE trajectory. The key wildcard is whether CRE net balance growth actually materializes in Q2 — if it does, NII guidance could be revised upward and the stock could re-rate; if payoffs remain elevated, NII will stay at the bottom of the range and the stock's recent outperformance could reverse.
Key Takeaway: Consensus is a moderate bar — achievable if CRE inflects and fees continue to outperform, but NII remains the swing factor given management’s own caution about the bottom half of the full-year range. Fee income is the upside lever; NII trajectory is the risk.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Est. | YoY Change | Mgmt Guidance | Cons. vs. Guidance |
Net Interest Income | $1,752M | $1,713M | $1,780M | +3.9% | $7.2B–$7.35B FY (bottom half); ~$1.78B–$1.84B implied Q2 | ~At low end of implied range |
EPS — Diluted Operating | $4.13 | $4.22 | $4.68 | +10.9% | No explicit EPS guidance; implied by NII + fee + expense guidance | N/A (no direct guidance) |
Total Noninterest Income (Fees) | $689M | $683M | $681M | -0.3% | Trending to exceed top of guidance range (mgmt signaled upside) | Consensus appears conservative vs. mgmt tone |
Net Interest Margin (FTE) | 3.71% | 3.62% | 3.68% | +6 bps | "High 3.60s" (NIM expected to drift modestly lower from Q1) | Consensus in line with guidance |
Provision for Credit Losses | $140M | $125M | $139M | +11.2% | No explicit guidance; credit quality improving (9 consecutive quarters) | Consensus slightly above Q1 actual; conservative |
ROTCE — Operating | 14.3% | 15.5% | 16.2% | +70 bps | Mid-to-high teens target; no specific Q2 guidance | Consensus implies meaningful sequential improvement |
CET1 Capital Ratio | 10.33% | 10.99% | 10.19% | -80 bps | Operating range 10%–10.5%; mgmt targeting lower end (~10%) | Consensus implies continued buyback pressure on ratio |
Total Noninterest Expenses (Operating) | $1,438M | $1,336M | $1,367M | +2.3% | Trending toward top of guidance range (per Q1 call) | Consensus below Q1 actual; may be too low |
Efficiency Ratio | 58.9% | 55.8% | 55.5% | -330 bps | No specific Q2 guidance; FY target implies improvement from Q1 | Consensus implies significant sequential improvement from Q1’s elevated 58.9% |
Source: Visible Alpha Consensus and Actuals Data. All consensus figures as of latest available. Q1 2026 actuals from MTB Q1 2026 earnings release (April 15, 2026). Guidance from Q1 2026 earnings call and subsequent conference appearances.
KPI 1: Net Interest Income (NII) | KPI 2: EPS — Diluted Operating
Quarter | NII Reported | NII Consensus | NII Surprise | NII Result | Op. EPS Reported | Op. EPS Consensus | EPS Surprise | EPS Result |
Q2 2024 | $1,718M | $1,693M | +1.5% | Beat | $3.79 | $3.53 | +7.4% | Beat |
Q3 2024 | $1,726M | $1,719M | +0.4% | Beat | $4.08 | $3.64 | +12.1% | Beat |
Q4 2024 | $1,728M | $1,723M | +0.3% | Beat | $3.92 | $3.77 | +4.0% | Beat |
Q1 2025 | $1,695M | $1,703M | -0.5% | Miss | $3.32 | $3.43 | -3.2% | Miss |
Q2 2025 | $1,713M | $1,740M | -1.6% | Miss | $4.22 | $4.00 | +5.6% | Beat |
Q3 2025 | $1,761M | $1,773M | -0.7% | Miss | $4.87 | $4.45 | +9.6% | Beat |
Q4 2025 | $1,779M | $1,783M | -0.2% | Miss | $4.68 | $4.50 | +4.0% | Beat |
Q1 2026 | $1,752M | $1,759M | -0.4% | Miss | $4.13 | $4.07 | +1.5% | Beat |
Pattern: MTB has beaten EPS consensus in 7 of the last 8 quarters (the sole miss was Q1 2025, a seasonally weak quarter), but has consistently missed NII consensus over the last 5 quarters — suggesting the street systematically overestimates NII while management’s conservative guidance leaves room for EPS beats via fee income and expense discipline. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Since Q1 2026 earnings, management’s tone has shifted from cautious to constructively optimistic — CRE growth conviction has materially increased and fee income guidance has been upgraded, while NII remains guided to the bottom half of the full-year range but with improving loan growth signals.
Topic | Q1 2026 Earnings (Apr 15) | Barclays Conference (May 5) | Morgan Stanley Conference (Jun 10) | Direction |
NII / Full-Year Guidance | Maintained $7.2B–$7.35B range; trending toward bottom half; NIM guided to "high 3.60s" | NIM expected to "come down some" but CRE recovery should help; no guidance change | Loan growth described as "very healthy"; customers drawing down lines — consistent with credit cycle inflection; NII headwinds may be abating | → Cautious but improving |
CRE Loan Growth | Acknowledged softer Jan/Feb; strong March production ($1B+); confident in growth "this year" | "CRE is going to grow this year, probably in the next quarter or two, very, very good positive momentum"; April also strong; payoffs abating | CRE improvement cited as driver of 9 consecutive quarters of improving credit trends; no new areas of concern | ↑ Upgraded to high conviction |
Fee Income | Fees grew 13% YoY in Q1; CFO said "may actually exceed our range"; sub-servicing ramp expected in H2 | "Really strong fee growth" expected; mortgage, capital markets, Bayview as key drivers; "not sure if we’ll get double-digit growth" but strong | Fee businesses "all kicking in concert"; 13% YoY growth highlighted; wealth, corporate trust, treasury management all performing well | ↑ Upgraded — consensus appears conservative |
Credit Quality | Criticized loans fell $700M+ in Q1 to $6.6B; nonaccruals best since 2007; 9 consecutive quarters of improvement | Portfolio "continues to improve"; non-accruals "best since ’07"; criticized assets projected to continue declining; $30–$40M reserve build from Moody’s Iran scenario overlay | 9 consecutive quarters of improving credit trends confirmed; nonperformers declining steadily; low-end consumer softness (gaming/entertainment) noted but not yet translating to delinquencies | → Stable / Positive surprise |
Capital / Buybacks | Q1 buyback >$1.25B (2x prior pace); CET1 at 10.33%, bottom of 10%–10.5% range; Basel endgame revisions could add ~100 bps CET1 | Plans to buy "a fair amount of shares this quarter, not as much as last quarter, but probably a little more than expected"; targeting ~6–7% of stock repurchased in 2026 | Tangible capital ratio ~1 full ppt above peers; risk transfer trades used at ~half industry median; new capital rules change loan-level economics favorably — multi-year capital efficiency opportunity | → Sustained aggression + regulatory tailwind |
Expenses | Trending toward top of guidance range; Q1 elevated at $1,438M due to seasonal comp; expects normalization | No specific update; fee-driven revenue growth expected to offset expense pressure | No specific update; efficiency ratio improvement expected as revenue recovers | → Unchanged / Slight risk to upside |
Key Takeaway: Estimates have been revised upward since Q1 earnings, with the Q2 2026 operating EPS consensus moving from ~$4.65 (pre-Q1 earnings, April 22 snapshot) to $4.68 currently — a modest but directionally positive revision that reflects improving fee and loan growth signals from management conferences.
KPI | Pre-Q1 Earnings Consensus (Apr 22 Snapshot) | Current Consensus (Latest) | Revision Direction | Commentary |
Q2 2026 NII | $1,780M | $1,780M | → Flat | NII estimates anchored near bottom of mgmt’s implied Q2 range; CRE inflection is the upside catalyst not yet priced in |
Q2 2026 Op. EPS | $4.65 | $4.68 | ↑ +$0.03 (+0.6%) | Modest upward revision post-Q1; fee income upgrade and buyback accretion driving incremental EPS lift |
Q2 2026 Fee Income | $678M | $681M | ↑ +$3M (+0.4%) | Consensus still appears conservative vs. mgmt’s "exceed the top of the range" signaling; upside risk here |
Q2 2026 Provision | $144M | $139M | ↓ -$5M (-3.5%) | Provision estimates edging lower as credit quality improvement streak continues; 9 consecutive quarters of improvement |
FY 2026 Op. EPS | N/A (snapshot not available) | $18.73 | N/A | FY 2026 consensus implies ~$4.68 average for remaining quarters; FY 2027 consensus at $20.85 implies continued earnings growth trajectory |
Source: Visible Alpha Consensus and Actuals Data. Pre-Q1 earnings snapshot as of April 22, 2026. Current consensus as of latest available.
Key Takeaway: MTB has outperformed both the regional bank ETF (KRE) and the S&P 500 since Q1 2026 earnings, rallying ~11% vs. KRE +8% and SPY +7% — the stock has partially priced in the improving narrative, but the CRE inflection and fee income upgrade have not been fully reflected in the multiple.
MTB vs. KRE vs. S&P 500 — Indexed Performance Since Q1 2026 Earnings (Apr 15, 2026 = 100). Source: Stock Price Data.
Metric | Value | Context |
MTB Price (Apr 15, 2026 close) | $217.10 | Q1 2026 earnings day close (muted reaction, broadly in-line results) |
MTB Price (Jul 14, 2026 close) | $241.85 | Current price heading into Q2 2026 earnings |
MTB Return Since Q1 Earnings | +11.4% | Outperforming KRE (+8.4%) and SPY (+7.4%) over same period |
KRE Return Since Q1 Earnings | +8.4% | Regional bank sector broadly rallied on improving credit and rate outlook |
SPY Return Since Q1 Earnings | +7.4% | Broad market recovery from April tariff-driven volatility |
52-Week Range (approx.) | $204 – $242 | Stock near 52-week highs heading into print; elevated bar for reaction |
Source: Stock Price Data. Returns calculated close-to-close from April 15, 2026 to July 14, 2026.
Stock Setup Commentary: MTB is trading near 52-week highs at ~$242, implying the market has already rewarded the improving credit narrative and management’s capital return aggression. At current prices, MTB trades at approximately 13x FY 2026 consensus operating EPS of $18.73 — a modest discount to large-cap bank peers but appropriate given its regional concentration. The stock’s outperformance vs. KRE since Q1 earnings reflects MTB-specific alpha from the fee income upgrade and CRE conviction signals. However, with the stock near highs, the asymmetry into the print is somewhat balanced: a CRE inflection beat could push the stock toward $255–$260, while a NII miss without CRE growth evidence could see a pullback toward $225–$230.
Key Takeaway: Peer commentary from Q2 2026 earnings calls (WFC, BAC, JPM — reported July 14) and post-Q1 conferences (KEY, FHN, ZION, RF, CFG, FITB, USB) paints a broadly constructive backdrop for MTB’s Q2 print — NII is recovering across the sector, loan growth is accelerating (especially C&I and CRE), credit quality remains benign, and fee income is outperforming. The read-through is positive for MTB’s key debates.
Note: Only commentary from post-Q1 2026 earnings conferences (May–June 2026) and Q2 2026 earnings calls (July 14, 2026) is included below, as these reflect current-quarter (Q2 2026) dynamics. Q1 2026 earnings call commentary from peers about their own Q1 results is excluded.
MTB Read-Through: Positive across NII, loan growth, and ROTCE.
MTB Read-Through: Positive on NII, credit quality, and consumer health.
MTB Read-Through: Positive on loan demand and capital markets; neutral on NIM.
MTB Read-Through: Positive on loan growth and NII; cautious note on credit plateauing.
MTB Read-Through: Positive on NII trajectory and loan demand; supportive of MTB’s bottom-half NII guidance being conservative.
MTB Read-Through: Positive on credit quality and deposit stability; supportive of MTB’s benign credit outlook.
MTB Read-Through: Positive on NII recovery and fee income; supportive of sector-wide improvement.
MTB Read-Through: Positive on loan utilization and NII; mild caution on deposit costs.
MTB Read-Through: Positive on commercial loan growth and credit quality.
MTB Read-Through: Positive on fee income and NII; supportive of sector-wide improvement.
Peer | Source / Date | Key Theme | MTB Read-Through | Signal |
WFC | Q2 2026 Earnings (Jul 14) | NII +5% YoY, +2% QoQ; loans +12% YoY; ROTCE 17.7%; NIM compression moderating | Sector NII recovery confirmed; NIM headwinds easing; ROTCE expansion supportive | Positive |
BAC | Q2 2026 Earnings (Jul 14) | Broad-based NII and fee income growth across all segments; credit quality benign | Sector-wide NII and fee recovery; credit quality supports lower provision | Positive |
JPM | Q2 2026 Earnings (Jul 14) | Strong C&I loan demand; capital markets fees elevated; consumer credit stable | C&I and capital markets fee tailwind; consumer credit stability supportive | Positive |
KEY | MS Conference (Jun 10) | NII +3% QoQ guided; C&I loans +$4B from year-end; CRE payoffs abating; credit plateauing | CRE payoff abatement is direct positive for MTB’s CRE inflection; NII recovery on track | Positive |
FHN | MS Conference (Jun 10) | NII guidance reiterated; loan pipelines healthy; commercial demand broad-based | Supports MTB’s bottom-half NII guidance being conservative if CRE inflects | Positive |
ZION | MS Conference (Jun 9) | Credit quality benign; CRE stabilizing in multifamily and industrial | CRE stabilization in MTB’s key origination segments; credit improvement durable | Positive |
CFG | Bernstein Conference (May 29) | NII recovery on track; fee income outperforming via capital markets and mortgage | Fee income upgrade not idiosyncratic to MTB; sector-wide strength | Positive |
RF | MS Conference (Jun 9) | Loan utilization picking up; deposit costs stabilizing | Utilization inflection supports MTB’s NII recovery; deposit cost stability positive for NIM | Positive |
FITB | MS Conference (Jun 10) | Commercial loan growth accelerating; credit quality stable | Broad-based commercial demand; credit stability supports provision normalization | Positive |
USB | MS Conference (Jun 10) | Fee income momentum; NII stabilizing on loan growth and deposit repricing | Fee and NII recovery durable across sector; supports MTB’s guidance upgrade | Positive |
Key Takeaway: Insider activity since Q1 2026 earnings is dominated by routine option exercises and director stock awards — no open-market purchases or unusual selling patterns that would signal a directional view ahead of Q2 earnings. The only notable open-market sales are small and on 10b5-1 plans.
Date | Insider | Role | Transaction | Shares | 10b5-1 Plan? | Interpretation |
Jul 1, 2026 | Woodrow, Tracy S. | Sr. EVP | Option exercise + sale (S) | 881 shares sold | Yes | Routine 10b5-1 plan execution; not a discretionary sell signal |
Jun 15, 2026 | Taylor, John R. | EVP & Controller | Option exercise + sale (S) | 1,098 shares sold | No | Small sale post-option exercise; not unusual for controller-level executive |
Jun 4, 2026 | Pearson, Kevin J. | Vice Chairman | Open-market sale (S) | 2,000 shares sold | Yes | 10b5-1 plan; pre-scheduled; retains 46,107 shares; not a bearish signal |
May 7, 2026 | Kay, Christopher E. | Sr. EVP | Open-market sale (S) | 3,105 shares sold | No | Largest discretionary sale in the period; retains 6,753 shares; modest in context |
Apr 30, 2026 | Multiple Directors (9) | Board of Directors | Stock award (A) | 664–687 shares each | N/A | Routine annual director compensation awards; no signal value |
Source: Insider Transaction Data (SEC Form 4 filings). Period: April 15, 2026 – July 14, 2026.
Assessment: The insider transaction picture is neutral-to-slightly-positive. There are no open-market purchases (which would be a strong bullish signal), but the selling activity is modest, largely on 10b5-1 plans, and concentrated among executives who retain substantial positions. Vice Chairman Pearson retains 46,107 shares after his 2,000-share 10b5-1 sale, and Sr. EVP Woodrow’s sale was a routine option exercise. The absence of any large discretionary selling by the CEO or CFO ahead of Q2 earnings is a mild positive signal.